Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan, providing innovative products and services in 29 countries/regions around the world. With more than 120 years of scientific expertise, the company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of 17,000 + employees worldwide, Daiichi-Sankyo create innovative new and generic medicines, and new methods of drug discovery and delivery – sharing a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.
What is the Digital Services Tax and Why Was it Crucial on Liberation Day?
There is growing tension between the UK and US over the Digital Services Tax, its potential impact on trade following Trump’s ‘Liberation Day’ tariffs, and the options facing the UK Government as it balances fair taxation with economic diplomacy.
